IL13 and eosinophilic esophagitis: The central role of IL-13 in EoE pathogenesis has been highlighted by several trials involving IL-13 monoclonal antibodies [39,40], which have demonstrated correlations with improvements in clinical, endoscopic, and histological outcomes.